As we wrap up Q4 and look ahead to 2025, we're?eager to see what therapeutic developments the new year will hold.?We have some ideas, but want to hear from you, too!?Vote in our poll and share your thoughts in the comments—what other disease areas do you think will take center stage in the new year? At Current, our biotech expertise includes?both corporate and product communications for therapeutic areas including but not limited to cardiovascular disease, diabetes, oncology, neuroscience, immunology, and rare disease.?Learn more about how we can help your biotech company breakthrough. Reach out to our healthcare team at?[email protected].
此处无法显示此内容
在领英 APP 中访问此内容等